Target CancerBreakthrough Cancer Treatment: Alpha Radiation Therapy by Dr. Robert Den | TARGET: Cancer Podcast | Ep. 67
The podcast episode features Dr. Sanjay Juneja interviewing Dr. Robert Den, a Harvard and Yale-trained physician and radiation oncologist. Dr. Den discusses the importance of trust in the patient-physician relationship and its impact on cancer treatment decisions. He emphasizes the need for personalized care, considering patients' individual circumstances and goals. Dr. Den introduces the innovative "DaRT" (Diffusing Alpha Radiation Therapy) technology, which targets tumors with alpha radiation, demonstrating promising results across various cancer types. He explains how this approach can offer new hope and treatment options, especially for patients with challenging cancer cases. The conversation highlights the potential of DART therapy to improve patient outcomes and quality of life.
- - - -TimeStamps - - - -
00:00 Introduction 06:51 Non-chemo options 12:42 Alpha radiation and DaRT technology 23:44 How DaRT technology works 32:44 Treatment stories
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. ROBERT DEN —
Dr. Den specializes in radiation oncology and conducts innovative research across a broad variety of malignancies. He serves as an associate professor and a clinical practitioner at Jefferson University. As a leading expert and accomplished clinician in the field, Dr. Den is responsible for furthering the company’s clinical and research operations. Dr. Den received his medical degree from Harvard Medical School in 2006. Today, his focus is on improving the lives of patients suffering from cancer through the incorporation of novel agents with radiation therapy.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Breakthrough Cancer Treatment: Alpha Radiation Therapy by Dr. Robert Den | TCP Ep.67Target Cancer2024-07-11 | Breakthrough Cancer Treatment: Alpha Radiation Therapy by Dr. Robert Den | TARGET: Cancer Podcast | Ep. 67
The podcast episode features Dr. Sanjay Juneja interviewing Dr. Robert Den, a Harvard and Yale-trained physician and radiation oncologist. Dr. Den discusses the importance of trust in the patient-physician relationship and its impact on cancer treatment decisions. He emphasizes the need for personalized care, considering patients' individual circumstances and goals. Dr. Den introduces the innovative "DaRT" (Diffusing Alpha Radiation Therapy) technology, which targets tumors with alpha radiation, demonstrating promising results across various cancer types. He explains how this approach can offer new hope and treatment options, especially for patients with challenging cancer cases. The conversation highlights the potential of DART therapy to improve patient outcomes and quality of life.
- - - -TimeStamps - - - -
00:00 Introduction 06:51 Non-chemo options 12:42 Alpha radiation and DaRT technology 23:44 How DaRT technology works 32:44 Treatment stories
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. ROBERT DEN —
Dr. Den specializes in radiation oncology and conducts innovative research across a broad variety of malignancies. He serves as an associate professor and a clinical practitioner at Jefferson University. As a leading expert and accomplished clinician in the field, Dr. Den is responsible for furthering the company’s clinical and research operations. Dr. Den received his medical degree from Harvard Medical School in 2006. Today, his focus is on improving the lives of patients suffering from cancer through the incorporation of novel agents with radiation therapy.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Watch the full vide: youtu.be/i5145ja_h-ELactic Acid: Friend or Foe in Cancer Battle?Target Cancer2024-10-14 | Ever wondered how cancer cells protect themselves from our body's defense systems? Lactic acid might be the answer! Dive into this fascinating exploration of cancer biology.
#shorts #CancerBiology #Research
Watch the full video with Dr. Jason Fung and Dr. Thomas Seyfried: youtu.be/ENllkzs5GpkBoosting Cancer Survival: The Power of Metabolic TherapyTarget Cancer2024-10-07 | 1700 people a day die from cancer in the US. We need to rethink our approach to clinical trials with innovative diet and drug combos. #shorts #MedicalBreakthrough #CancerAwarenessHow Data Networks Will Save Healthcare with Therasa Bell | TCP Ep. 72Target Cancer2024-10-07 | How Data Networks Will Save Healthcare with Therasa Bell | TARGET: Cancer Podcast | Ep. 72
In this engaging episode of the 'Target: Cancer Podcast,' Dr. Sanjay Juneja discusses the future of healthcare data with Therasa Bell, President, CTO, and co-founder of Kno2. Covering themes of healthcare inefficiencies, the importance of data sharing, and the critical need for innovation, this conversation dives deep into ways to tackle pressing concerns such as the aging population, provider shortages, and the sustainability of healthcare systems. You'll discover why data is seen as an underlying theme essential for solving these inherent issues and what measures are being taken at state and federal levels to improve the situation.
- - - -TimeStamps - - - -
00:00 Introduction 02:25 The Birth of a Healthcare Communication Network 07:23 The Role of Federal Government in Healthcare Data 21:49 The Importance of Data in Healthcare 34:02 Patient Consent and Data Networks 48:12 The Role of Providers in Data Integration
- - - - #cancertreatments #healthcare #data
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT THERASA BELL —
Combining her passion for healthcare and extensive technology expertise, Therasa Bell created Kno2 as market forces began to drive more effective, lighter-weight healthcare solutions. With her leadership and drive to solve some of the most persistent challenges facing healthcare, Kno2 continues to create lightweight solutions that enable patient information to be captured and shared across the continuum of care.
As Co-Founder, President, and Chief Technology Officer, Therasa defines the business vision for Kno2 and paves a clear path of execution for the staff. She is responsible for Kno2’s innovation, vision and engineering, and holds two patents for unstructured clinical content under the company. She believes that the combination of people and the company’s clear purpose makes Kno2 unstoppable.
For close to a decade, Therasa has been a thought leader in the healthcare information technology field, serving as a co-chair or member of healthcare IT standards committees that influence national and international standards for sharing clinical information. In 2009, she defined and pushed through a healthcare IT protocol for unstructured clinical content, which passed as part of legislation for the Meaningful Use Stage 2 section of the HITECH Act.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Views expressed by Dr. Juneja and our guests are solely their own, and not attributable to xCures, Tempus, or any of our guest's affiliations.
#shortsThe growing cancer risk in obesityTarget Cancer2024-09-26 | In this insightful segment of our last episode, we explore the critical relationship between glucose, insulin, and colorectal and breast cancer development.
Watch the full video at: youtu.be/ENllkzs5Gpk.¿Puede una dieta cetogénica eliminar el crecimiento del cáncer? El Dr. Thomas Seyfried dice que síTarget Cancer2024-09-26 | ¿Puede una dieta cetogénica eliminar el crecimiento del cáncer? El Dr. Thomas Seyfried dice que sí | TARGET: Cancer Podcast | Ep. 42
En este episodio, el Dr. Thomas Seyfried analiza enfoques metabólicos para el cáncer. Aprende cómo privar a las células cancerosas de combustibles fermentables como la glucosa y la glutamina puede hacer que se mueran de hambre y sean eliminadas. Cuestiona el modelo de enfermedad genética y descubre el impacto de la cetosis en la salud mitocondrial. Descubre la verdad sobre el cáncer como una enfermedad metabólica, no genética. Empodérate con el conocimiento para combatir el cáncer mediante estrategias metabólicas y aprende sobre los peligros que nos rodean, como los alimentos procesados.
Tiempos - - - - 00:00 Introducción 01:16 ¿Qué alimenta al tumor? 06:46 Cetosis 12:06 La estrategia de presionar y pulsar 18:07 Dieta y estilo de vida 25:40 Alimentos procesados 36:31 Índice Glucosa-Cetona
🔴¡Dale Like, Suscríbete y Comparte para ver más contenido de este tipo!
— ACERCA DEL DR. THOMAS SEYFRIED —
Thomas N. Seyfried es Profesor de Biología en Boston College y obtuvo su doctorado en Genética y Bioquímica de la Universidad de Illinois, Urbana, en 1976. También tiene una Maestría en Genética de la Universidad Estatal de Illinois, en Normal, IL. Thomas Seyfried sirvió con distinción en la Primera División de Caballería del Ejército de los Estados Unidos durante la Guerra de Vietnam, recibiendo numerosas medallas y condecoraciones. Fue becario postdoctoral en el Departamento de Neurología de la Escuela de Medicina de la Universidad de Yale y formó parte de su cuerpo docente. Actualmente, participa en varios comités editoriales, entre ellos los de Nutrition & Metabolism, Neurochemical Research, el Journal of Lipid Research, Frontiers in Nutrition, Frontiers in Oncology y ASN Neuro, donde es Editor Senior. El Dr. Seyfried tiene más de 190 publicaciones revisadas por pares y es autor del libro Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press). Su libro fue traducido recientemente al chino, y la lista completa de sus publicaciones revisadas por pares se puede encontrar en PubMed.
— ACERCA DEL DR. SANJAY JUNEJA —
El Dr. Sanjay Juneja es un hematólogo y oncólogo certificado en tres especialidades, que se desempeña como Jefe del Servicio de Oncología en el Hospital General de Baton Rouge. Es una personalidad de redes sociales y noticias conocida como 'TheOncDoc', con más de medio millón de seguidores, y uno de los quince médicos en redes sociales que participa en la serie Healthcare Leaders in Social Media Round Table para la Casa Blanca.
Ha sido destacado por The Washington Post, así como en docenas de podcasts nacionales y canales de noticias regionales (PBS, CBS, NBC, NPR), y ha dado discursos como invitado principal, además de colaborar con la American Cancer Society, BeTheMatch, la Sociedad de Leucemia y Linfoma, la Universidad de Harvard, el Departamento de Salud de Luisiana y varias otras organizaciones.
— ACERCA DE xCURES —
La plataforma de xCures es un portal directo al paciente y directo al médico que identifica las opciones de tratamiento más prometedoras para pacientes con cáncer avanzado que no responden a las terapias estándar.
La plataforma captura datos que también ayudan a acelerar el desarrollo de nuevos fármacos contra el cáncer, ampliar los usos aprobados de los fármacos existentes y demostrar valor para el reembolso.
In this eye-opening episode, Dr. Sanjay Juneja teams up with leading experts Dr. Jason Fung and Dr. Thomas Seyfried to reveal the shocking truth about what really drives cancer growth. Forget everything you thought you knew — this isn’t just about genetics! They dive into the powerful connection between diet, insulin, and metabolism, and how controlling sugar and inflammation might hold the key to stopping cancer in its tracks. If you’ve ever wondered whether cancer can be "starved," this is the conversation you need to hear. Tune in for a mind-blowing discussion that could revolutionize cancer treatment!
TARGET: Cancer Podcast is also available on all streaming platforms and xcures.com/tcp
TARGET: Cancer Podcast is hosted by Sanjay Juneja, M.D., and brought to you by xCures
#shorts #keto #cancerresearch #metabolichealthBreaking Myths: What Really Fuels Cancer Growth, with Dr. Fung and Dr. Seyfried | TCP Ep. 71Target Cancer2024-09-19 | Breaking Myths: What Really Fuels Cancer Growth, with Dr. Fung and Dr. Seyfried | TARGET: Cancer Podcast | Ep. 71
In this eye-opening episode, Dr. Sanjay Juneja teams up with leading experts Dr. Jason Fung and Dr. Thomas Seyfried to reveal the shocking truth about what really drives cancer growth. Forget everything you thought you knew—this isn’t just about genetics! They dive into the powerful connection between diet, insulin, and metabolism, and how controlling sugar and inflammation might hold the key to stopping cancer in its tracks. If you’ve ever wondered whether cancer can be "starved," this is the conversation you need to hear. Tune in for a mind-blowing discussion that could revolutionize cancer treatment!
- - - -TimeStamps - - - -
00:00 Introduction 01:33 The Role of Insulin and Sugar 06:40 Genetic vs. Environmental Factors 14:34 Mitochondrial Health 37:01 Cachexia and Cancer Metabolism 44:02 Immunotherapies
- - - - #obesity #keto #cancerresearch
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. THOMAS SEYFRIED —
Thomas N. Seyfried is Professor of Biology at Boston College, and received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He also holds a Master's degree in Genetics from Illinois State University, Normal, IL. Thomas Seyfried served with distinction in the United States Army’s First Cavalry Division during the Vietnam War, and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and served on the faculty. He serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, Frontiers in Nutrition, Frontiers in Oncology, and ASN Neuro, where his is a Senior Editor. Dr. Seyfried has over 190 peer-reviewed publications and is author of the book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).
— ABOUT DR. JASON FUNG —
Jason Fung, MD, was born in 1973 and trained in Los Angeles and Toronto as a kidney specialist. He founded The Fasting Method (TheFastingMethod.com) to provide evidence-based advice for weight loss and managing blood sugars, focusing on low carbohydrate diets and intermittent fasting. It has become obvious that conventional medical treatments are failing patients. Many of today’s chronic medical issues are related to diet and obesity, yet treatments are focused on medications and surgeries. If you don’t deal with the root cause, the problem never improves. A dietary problem requires a dietary solution. Dr. Fung is the author of The Obesity Code, The Complete Guide to Fasting, and The Diabetes Code.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House. He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Dr. Sungwon Lim from ImpriMed, Inc. explains the science and business advantages behind this decision.
Watch the full episode on YouTube: youtube.com/watch?v=SZqi9drwxmEDr. Seyfried and Dr. Fungs new interview coming at September 19Target Cancer2024-09-13 | 🔥 Get ready for an electrifying episode of the Target: Cancer podcast! 🎙️ We are thrilled to welcome back two of our most popular guests, Dr. Seyfried and Dr. Fung. With over 1 million views combined on their previous episodes, these experts are returning to dive deeper into groundbreaking discussions on cancer treatment. Don't miss out on this highly anticipated conversation.
September 19 on our YouTube channel.Align research innovation with clinical needsTarget Cancer2024-09-11 | 💡 "Creating the future of medicine with doctors' needs in mind." Dr. Lim from Imprimed discusses how to align research innovation with clinical needs. Watch the full episode with Dr. Lim from Imprimed on YouTube: youtube.com/watch?v=SZqi9drwxmE
#shorts #Medicine #DoctorCollaboration #ClinicalInnovation #ImprimedFrom Dogs to Humans: The Power of Precision Medicine with Dr. LimTarget Cancer2024-09-07 | New TARGET: Cancer Podcast episode is out!
Dr. Lim from Imprimed takes us through the evolution of personalized cancer therapy, starting from animal trials and advancing to human treatments. He explains how artificial intelligence is playing a critical role in creating precise and effective treatment plans in oncology. Explore the impact of AI in transforming cancer care by offering more personalized therapies, and how precision medicine is shaping the future of patient outcomes.
TARGET: Cancer Podcast is also available on all streaming platforms and xcures.com/tcp
TARGET: Cancer Podcast is hosted by Sanjay Juneja, M.D., and brought to you by xCures
#Shorts #precisionmedicine #animalhealth #medicaltechnologyFrom Dogs to Humans: The Power of Precision Medicine with Dr. Lim | TCP Ep. 70Target Cancer2024-09-05 | From Dogs to Humans: The Power of Precision Medicine with Dr. Lim | TARGET: Cancer Podcast | Ep. 70
Dr. Lim takes us through the evolution of personalized cancer therapy, starting from animal trials and advancing to human treatments. He explains how artificial intelligence is playing a critical role in creating precise and effective treatment plans in oncology. Explore the impact of AI in transforming cancer care by offering more personalized therapies, and how precision medicine is shaping the future of patient outcomes.
- - - -TimeStamps - - - -
00:00 - Introduction 02:54 - Combination Chemotherapy and Its Challenges 09:05 - Transition to Veterinary Oncology 18:39 - Preserving Tumor Microenvironment 27:10 - Predicting Treatment Outcomes 33:46 - Evaluating Treatment Responses and Toxicity 43:26 - The Role of Machine Learning in Cancer Treatment
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. SUNGWON LIM —
Dr. Sungwon Lim is the CEO and Co-Founder of ImpriMed, Inc., a pioneering company that leverages artificial intelligence to analyze live cancer cells and predict patient responses to cancer therapies before treatment. With a PhD in Bioengineering from Stanford University and a master’s degree in Translational Medicine from the UC Berkeley–UCSF Joint Bioengineering Program, Dr. Lim brings over 20 years of experience in both academia and the biotech industry. His work primarily focuses on the development of novel cancer therapies, and he is a passionate advocate for functional precision medicine, which tailors cancer treatments based on the functional responses of individual patients' cancer cells to various drugs, rather than solely relying on genetic information. As a bioengineer and entrepreneur, Dr. Lim is dedicated to advancing personalized cancer care through innovative approaches that integrate technology and medicine.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Watch the full episode with Dr. Sam Blackman from Day One Biopharmaceuticals on YouTube: youtu.be/1g5u_fhPvEc
#shorts #BrainCancer #MedicalInnovation #CancerTherapy #Neuroscience #ChildhoodCancer #DayOneBiopharmaceuticalsAdvances in Targeted Therapies for Brain TumorsTarget Cancer2024-08-30 | Innovative Strategies Targeting Brain Tumors: Advances and Techniques Explore the cutting-edge strategies in brain tumor treatment, focusing on signal transduction inhibitors, DNA damage response inhibitors, and CAR-T cell therapies. Learn about targeted therapies for BRAF mutations, mechanisms of DNA damage repair inhibition, and novel cell therapy delivery methods.
Watch the full interview to dive deeper into these transformative approaches: youtu.be/1g5u_fhPvEc.Most Anticipated Episode! Dr. Seyfried & Dr. Fung Speak Again | Target: CancerTarget Cancer2024-08-28 | 🔥 Get ready for an electrifying episode of the Target: Cancer podcast! 🎙️ We are thrilled to welcome back two of our most popular guests, Dr. Seyfried and Dr. Fung. With over 1 million views combined on their previous episodes, these experts are returning to dive deeper into groundbreaking discussions on cancer treatment. Don't miss out on this highly anticipated conversation. September 19 on our YouTube channel.
#shorts #seyfried #fungDevelopmental Errors Leading to Cancer: Investigating Leukemia in Fetal Blood SamplesTarget Cancer2024-08-26 | How does a single error in early development lead to cancer? Dr. Sam Blackman dives into the science of gene fusions and their link to leukemia. Find out more in the full episode on YouTube: youtu.be/1g5u_fhPvEc
#shorts #Biopharma #CancerAwareness #HealthTech #LeukemiaInnovative Treatments in Pediatric Neuro-Oncology with Dr. Sam BlackmanTarget Cancer2024-08-26 | New TARGET: Cancer Podcast episode is out!
Join Dr. Sanjay Juneja as he talks with Dr. Sam Blackman about advancements in Pediatric Neuro-Oncology. Dr. Blackman shares his journey from philosophy to medicine, discusses innovative treatments for pediatric brain cancer, and explores the role of AI in neuro-oncology. Discover insights into the latest therapies and the future of brain cancer treatment for children in this episode. Gain a deeper understanding of the challenges and breakthroughs in treating pediatric brain tumors.
TARGET: Cancer Podcast is also available on all streaming platforms and xcures.com/tcp
TARGET: Cancer Podcast is hosted by Sanjay Juneja, M.D., and brought to you by xCures.
#shorts #pediatriconcologyInnovative Treatments in Pediatric Neuro-Oncology with Dr. Sam Blackman | TCP Ep.69Target Cancer2024-08-23 | Innovative Treatments in Pediatric Neuro-Oncology with Dr. Sam Blackman | TARGET: Cancer Podcast | Ep. 69
Join Dr. Sanjay Juneja as he talks with Dr. Sam Blackman about advancements in Pediatric Neuro-Oncology. Dr. Blackman shares his journey from philosophy to medicine, discusses innovative treatments for pediatric brain cancer, and explores the role of AI in neuro-oncology. Discover insights into the latest therapies and the future of brain cancer treatment for children in this episode. Gain a deeper understanding of the challenges and breakthroughs in treating pediatric brain tumors.
- - - -TimeStamps - - - -
00:00 - Introduction 02:14 - From Philosophy to Medicine 10:10 - Challenges in Treating Brain Tumors 20:42 - Drug Development for Brain Tumors 30:30 - Innovations in Brain Tumor Treatments
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. SAM BLACKMAN —
Samuel C. Blackman, MD, PhD is co-founder and Chief Medical Officer of Day One Biopharmaceuticals. Sam is a physician-scientist trained in pediatric hematology/oncology and neuro-oncology, and has led the early clinical development of more than 10 novel cancer therapeutics. Prior to founding Day One, Dr. Blackman held roles of increasing responsibility at both large pharmaceutical companies and smaller biotechnology companies include Juno Therapeutics, Seattle Genetics, Merck, and GlaxoSmithKline. Dr. Blackman was responsible for the pediatric development of dabrafenib, resulting in the first industry-sponsored pediatric oncology “basket trial”. Through roles at CureSearch and ACCELERATE, Dr. Blackman is an active leader in the pediatric oncology drug development community. Dr. Blackman is a graduate of the pediatric hematology/oncology fellowship program at the Dana-Farber Cancer Institute and Children’s Hospital Boston, and the pediatric residency program at Cincinnati Children’s Hospital Medical Center. He received his MD and PhD degrees from the University of Illinois at Chicago.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
#shorts #colorectalcancer #dietandcancer #jasonfungWhy Colorectal Cancer Research Funding Needs Your SupportTarget Cancer2024-08-07 | Watch the full episode on our YouTube channel with Michael Sapienza, CEO of Colorectal Cancer Alliance @ColorectalCancerAlliance who discusses the latest developments in the fight against colorectal cancer. youtu.be/Pmr6giXmwCs
#shortsUnlocking the Power of Data in a Capitalist SocietyTarget Cancer2024-08-06 | Watch the full episode on our YouTube channel with Michael Sapienza, CEO of Colorectal Cancer Alliance @colorectalcanceralliance who discusses the latest developments in the fight against colorectal cancer. youtu.be/Pmr6giXmwCs
#shortsThe Best Colon Cancer Screening TestsTarget Cancer2024-08-02 | Watch the full episode on our YouTube channel with Michael Sapienza, CEO of Colorectal Cancer Alliance @ColorectalCancerAlliance who discusses the latest developments in the fight against colorectal cancer. youtu.be/Pmr6giXmwCs
#shortsBe Your Own Health Advocate Recognizing Key Gi SymptomsTarget Cancer2024-08-01 | Want to learn more? Watch the full video with Michael Sapienza, CEO of the Colorectal Cancer Alliance: youtu.be/Pmr6giXmwCsEarly Detection and Innovative Solutions for Colorectal Cancer with Michael SapienzaTarget Cancer2024-07-25 | New TARGET: Cancer Podcast episode is out!
In this episode of the Target: Cancer Podcast, Dr. Sanjay Juneja dives deep into the latest developments in colorectal cancer with Michael Sapienza, CEO of the Colorectal Cancer Alliance. Michael shares his personal journey from professional musician to leading cancer advocate, inspired by his mother’s battle with the disease. Discover the urgent need for innovative treatments and how advancements in AI and data sharing can revolutionize colorectal cancer care. Learn about cutting-edge screening methods, the critical importance of early detection, and the ongoing efforts to improve funding and research for colorectal cancer prevention.
TARGET: Cancer Podcast is also available on all streaming platforms and xcures.com/tcp
TARGET: Cancer Podcast is hosted by Sanjay Juneja, M.D.
#shorts #cancertreatment #colorectalcancer #cancerresearch #earlydetectionEarly Detection and Innovative Solutions for Colorectal Cancer with Michael Sapienza | TCP Ep.68Target Cancer2024-07-25 | Early Detection and Innovative Solutions for Colorectal Cancer with Michael Sapienza | TARGET: Cancer Podcast | Ep. 68
In this episode of the Target: Cancer Podcast, Dr. Sanjay Juneja dives deep into the latest developments in colorectal cancer with Michael Sapienza, CEO of the Colorectal Cancer Alliance. Michael shares his personal journey from professional musician to leading cancer advocate, inspired by his mother’s battle with the disease. Discover the urgent need for innovative treatments and how advancements in AI and data sharing can revolutionize colorectal cancer care. Learn about cutting-edge screening methods, the critical importance of early detection, and the ongoing efforts to improve funding and research for colorectal cancer prevention.
- - - -TimeStamps - - - -
00:00 - Introduction 02:16 - Michael Sapienza's Personal Story 05:50 - Current State of Colorectal Cancer Treatment 11:10 - Importance of Early Detection and Screening 25:20 - Innovative Screening Methods 33:44 - Advocacy and Funding for Research
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT MICHAEL SAPIENZA —
Michael Sapienza is the Chief Executive Officer of the Colorectal Cancer Alliance, the largest colon cancer advocacy group in the country. He lost his mother to colorectal cancer in May 2009. He turned his profound grief into action, inspiring and challenging the colorectal cancer community, family, friends, and professional associates to follow his lead and dedicate themselves to ending colorectal cancer within our lifetime—the mission of the Colorectal Cancer Alliance. Michael founded The Chris4Life Colon Cancer Foundation and served as its President from 2010-2015. In 2016, he led the team that merged the Foundation and the Colon Cancer Alliance, creating the nation’s largest colon cancer specific nonprofit, which changed its name to Colorectal Cancer Alliance in 2017 to embrace both the colon and rectal cancer communities.
Over the last decade, Michael has become an expert and trusted voice on the topics of colorectal cancer prevention, patient care, and medical research. Michael regularly appears on TV and radio programs throughout the United States, including NBC’s TODAY show. He is frequently quoted in national publications such as USA Today, Newsweek, and The New York Times, promoting awareness and the importance of increased funding for colorectal cancer research and early detection. In 2022, Michael spearheaded a partnership with Maximum Effort, Ryan Reynolds’ marketing agency to build a new initiative called Lead From Behind. This new Alliance initiative has garnered over 3.5 billion media impressions.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
#shortsBreakthrough Cancer Treatment: Alpha Radiation Therapy by Dr. Robert DenTarget Cancer2024-07-15 | New TARGET: Cancer Podcast episode is out!
The podcast episode features Dr. Sanjay Juneja interviewing Dr. Robert Den, a Harvard and Yale-trained physician and radiation oncologist. Dr. Den discusses the importance of trust in the patient-physician relationship and its impact on cancer treatment decisions. He emphasizes the need for personalized care, considering patients' individual circumstances and goals. Dr. Den introduces the innovative "DaRT" (Diffusing Alpha Radiation Therapy) technology, which targets tumors with alpha radiation, demonstrating promising results across various cancer types. He explains how this approach can offer new hope and treatment options, especially for patients with challenging cancer cases. The conversation highlights the potential of DART therapy to improve patient outcomes and quality of life.
TARGET: Cancer Podcast is also available on all streaming platforms and xcures.com/tcp
TARGET: Cancer Podcast is hosted by Sanjay Juneja, M.D.
#shorts #alpharadiation3d Microtumor Models: Double Treatment SuccessTarget Cancer2024-07-05 | Watch the full video of "Personalized Cancer Therapies Explained by Dr. Apfel": youtu.be/iwdZ_D4OJ2w
Dr. Chris Apfel explores innovative AI technology in cancer treatment, emphasizing early detection and personalized therapies. By utilizing real tissue testing to determine optimal drug responses, this method aims to enhance patient outcomes. Discover how this advancement is transforming cancer care and advancing precision medicine. Join Dr. Apfel on the Target: Cancer Podcast to delve into the future of customized treatments.Personalized Cancer Therapies Explained by Dr. ApfelTarget Cancer2024-07-01 | New TARGET: Cancer Podcast episode is out!
Dr. Chris Apfel explores innovative AI technology in cancer treatment, emphasizing early detection and personalized therapies. By utilizing real tissue testing to determine optimal drug responses, this method aims to enhance patient outcomes. Discover how this advancement is transforming cancer care and advancing precision medicine. Join Dr. Apfel on the Target: Cancer Podcast to delve into the future of customized treatments.
TARGET: Cancer Podcast is also available on all streaming platforms and xcures.com/tcp
TARGET: Cancer Podcast is hosted by Sanjay Juneja, M.D. @theoncdoc
#shorts #cancertreatment #earlydetection #cancerscreening #cancertherapyPersonalized Cancer Therapies Explained by Dr. Apfel | TCP Ep. 66Target Cancer2024-06-29 | Personalized Cancer Therapies Explained by Dr. Apfel | TARGET: Cancer Podcast | Ep. 66
Dr. Chris Apfel explores innovative AI technology in cancer treatment, emphasizing early detection and personalized therapies. By utilizing real tissue testing to determine optimal drug responses, this method aims to enhance patient outcomes. Discover how this advancement is transforming cancer care and advancing precision medicine. Join Dr. Apfel on the Target: Cancer Podcast to delve into the future of customized treatments.
- - - -TimeStamps - - - -
00:00 Introduction 01:42 Challenges in Cancer Treatment 08:18 Innovative Approaches and Technologies 13:26 AI and Precision Medicine 20:45 Combination Therapies and Multimodal Approaches 32:16 Biopsy and Tumor Evolution
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. CHRIS APFEL —
Christian Apfel is internationally recognized for changing medical practice by bringing innovation to millions of patients by designing and executing on highest quality clinical research. One of his most notable innovations, the “Apfel Score,” is now used in clinical practice globally. Chris has turned his attention to precision medicine and is the founder and CEO of SageMedic Corporation. SageMedic redefines precision medicine with its SAGE Direct Platform to help millions of cancer patients to identify the most effective treatment by overcoming limitations inherent to genome-driven targeted therapy. He has published more than 100 peer-reviewed publications and is an Adjunct Professor at UCSF. He is an investor with Life Science Angels and the chair of the life science committee at the Keiretsu Forum. Chris is a California licensed physician and received his MD/PhD from Justus-Liebig-Universität Giessen, Germany, and his an MBA from Wharton, University of Pennsylvania, PA.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
#shortsThe power of wearables to predict health issuesTarget Cancer2024-06-27 | Watch the full video with Danie Kraft. Explore AI, wearables, and digital health in cancer care, and the potential of multiomics data and predictive analytics to revolutionize patient outcomes.
#shortsThe Future of Medicine The Power of Genomic Data.Target Cancer2024-06-20 | The Future of Medicine The Power of Genomic Data.
If you missed the full episode with David Hysong and Kate Arline from Shepherd Health, be sure to check out our YouTube channel: youtu.be/XZ9xtByAhxU
#shortsThe Future of Healthcare: AI and Wearables with Dr. Daniel KraftTarget Cancer2024-06-17 | The Future of Healthcare: AI and Wearables with Dr. Daniel Kraft
#shorts
Watch now on our YouTube channel: youtu.be/3xZf2f8LMxUThe Future of Healthcare: AI and Wearables with Dr. Daniel Kraft | TCP Ep. 65Target Cancer2024-06-16 | The Future of Healthcare: AI and Wearables with Dr. Daniel Kraft | TARGET: Cancer Podcast | Ep. 65
Discover the future of healthcare with Dr. Daniel Kraft on the Target: Cancer Podcast. Explore AI, wearables, and digital health in cancer care, and the potential of multiomics data and predictive analytics to revolutionize patient outcomes. Find out more about integrating cutting-edge advancements into everyday practice and navigating the evolving healthcare landscape. Don't miss this riveting exploration of technology, medicine, and innovation.
- - - -TimeStamps - - - -
00:00 Introduction 03:07 The Importance of Innovation 06:50 Role of Technology in Healthcare 19:56 Collecting Data from Wearables 26:04 Regulatory Barriers 27:58 Practical Applications and Future Directions 36:25 Digital Health Platforms and Tools
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR DANIEL KRAFT —
Daniel is a Harvard & Stanford trained physician-scientist who lives at the interface of healthcare, technology & innovation. He founded, chaired and curated Exponential Medicine for a decade before evolving it to NextMed Health. He is an Aspen Institute Health Innovation Fellow and Kaufman fellow. Following medical school at Stanford, & Medicine/Peds training at the MGH, he completed fellowships in hematology/oncology & bone marrow transplantation. He is heavily involved as an innovator & investor in digital health and medtech, and has given 4 TEDTalks focused on the future of health & biomedicine.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
#shortsCancer Risks in the Kitchen: Plastic and Processed Meats HazardTarget Cancer2024-06-12 | Full video available on our YouTube channel.
#shortThe Hidden Dangers in Beauty Products: A Case for Going Phthalate-FreeTarget Cancer2024-06-05 | Full video available on our YouTube channel.
#shortHow Everyday Exposures Increase Cancer Risk | TCP Ep. 64Target Cancer2024-06-01 | How Everyday Exposures Increase Cancer Risk | TARGET: Cancer Podcast | Ep. 64
Investigative reporter Kristina Marusic delves into the connection between environmental exposures and cancer risk, sharing her sister's diagnosis and the effects of everyday chemicals. She emphasizes reducing pesticide exposure, filtering air and water, and using safer personal care products. Marusic advocates for regulatory changes and encourages listeners to urge lawmakers to prioritize cancer prevention. Tune in to discover how small lifestyle changes can significantly lower cancer risk.
- - - -TimeStamps - - - -
00:00 Introduction 02:04 Investigating Environmental Links to Cancer 09:00 Cancer Risk and Multifactorial Chemical Exposures 13:07 Pesticide Exposure 19:33 Effective Indoor Air Filtration Strategies 27:52 Chemical Exposure From Personal Care Items 39:52 Danger of Plastics 44:32 Safe Product Choices - - - - #cancertreatment #environment #cancerrisk #airpollution #chemicals
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT KRISTINA MARUSIC —
Kristina is an author and journalist. She works full time for Environmental Health News, covering issues related to environmental health and justice. Her first book, "A New War on Cancer: The Unlikely Heroes Revolutionizing Prevention," was published on May 11, 2023. It's about an emerging national movement focused on fighting cancer by stopping widespread exposure to carcinogenic chemicals, and it's available in bookstores everywhere. She has received recognition or awards from the Society of Environmental Journalists, the Association of Health Care Journalists, the Society of Professional Journalists, the National Institute of Health Care Management, the Group Against Smog and Pollution, and the Carnegie Science Center for her reporting on environmental health and justice. She is also the co-founder of the Pittsburgh chapter of the National Association of LGBTQ Journalists (a.k.a. NLGJA). She previously worked as a freelance journalist covering LGBT equality, feminism, social and environmental justice, activism, and politics with bylines at CNN, Slate, Vice, Women's Health, the Washington Post, MTV News, The Advocate, Logo TV's NewNowNext, and Bustle, among many others. She believes that true, well-told stories have the power to change the world for good. She holds an MFA in Creative Nonfiction and proudly considers herself a word nerd. Her narrative essays have appeared in literary magazines including Creative Nonfiction and Flyway.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.